US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Fibromyalgia Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 670
Acute Myeloid Leukemia Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... It covers emerging therapies for Acute Myeloid Leukemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 670
Acute Myocardial Infarction Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... It covers emerging therapies for Acute Myocardial Infarction in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 670
Acute Pain Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... therapies for Acute Pain in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 670
Amyotrophic Lateral Sclerosis Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... It covers emerging therapies for Amyotrophic Lateral Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 670
Urinary Tract Infections Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... It covers emerging therapies for Urinary Tract Infections in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 670
Respiratory Disorders Pipeline Highlights Database – 2015 Update
7/1/2015 | published by: Fore Pharma
... therapies for Respiratory Disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Chronic obstructive pulmonary disease, Sinusitis (Acute and Chronic), Asthma, Bronchitis (Acute and ...  |  read more...
USD 2,800
Vaccine Pipeline Highlights Database – 2015 Update
7/1/2015 | published by: Fore Pharma
... active clinical development stages including early and late stage clinical trials. The pipeline data is presented in an excel dashboard with filtering options. The pipeline data presented in this report helps executives for tracking competition, ...  |  read more...
USD 970
Colon Cancer Treatment Drugs Markets in China
7/1/2015 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Inflammatory Pain Global Clinical Trials Review, H1, 2015
6/25/2015 | published by: GlobalData
... line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Global Ocular Anti-Allergics and Decongestants Market Highlights - 2015
7/1/2015 | published by: Fore Pharma
... landscape, and Ocular Anti-Allergics and Decongestants products sales. The research includes global Ocular Anti-Allergics and Decongestants market size estimates for 2014, Ocular Anti-Allergics and Decongestants products market share, and Ocular Anti-Allergics and Decongestants products sales ...  |  read more...
USD 790
Global Ocular Antineovascularisation Products Market Highlights - 2015
7/1/2015 | published by: Fore Pharma
... Antineovascularisation Products products sales. The research includes global Ocular Antineovascularisation Products market size estimates for 2014, Ocular Antineovascularisation Products products market share, and Ocular Antineovascularisation Products products sales estimates. This research helps executives track competitor ...  |  read more...
USD 790
US Ophthalmological Anti-Infectives Market Highlights - 2015
7/1/2015 | published by: Fore Pharma
... in the US. The research includes US Ophthalmological Anti-Infectives market size estimates for 2014, Ophthalmological Anti-Infectives products market share, and Ophthalmological Anti-Infectives products sales estimates. This research helps executives track competitor product sales and market ...  |  read more...
USD 790
US Ophthalmological Corticosteroids Market Highlights - 2015
7/1/2015 | published by: Fore Pharma
... in the US. The research includes US Ophthalmological Corticosteroids market size estimates for 2014, Ophthalmological Corticosteroids products market share, and Ophthalmological Corticosteroids products sales estimates. This research helps executives track competitor product sales and market ...  |  read more...
USD 790
Opioid Addiction Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... therapies for Opioid Addiction in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 670
Europe Opioid Dependence Drugs Market Highlights - 2015
7/1/2015 | published by: Fore Pharma
... Dependence Drugs products sales in Europe. The research includes Europe Opioid Dependence Drugs market size estimates for 2014, Opioid Dependence Drugs products market share, and Opioid Dependence Drugs products sales estimates. This research helps executives ...  |  read more...
USD 790
Osteoarthritis Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 670
Parkinson's Disease Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... therapies for Parkinson's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 670
Conference Documentation: Lyophilisation -Europe
6/30/2015 | published by: SMI Publishing, Ltd
... of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines. As under met needs in drug transport and long term storage continues to prevail, robust lyophilisation methods ...  |  read more...
USD 788.78
Nasal Obstruction Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... line data relating to the clinical trials on Nasal Obstruction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Angiogenesis in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... number of ceased drugs over the last years amount to another 215 drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...  |  read more...
USD 6,750
Apoptosis in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... cancer cells. There are today 426 companies plus partners developing 550 apoptotic drugs in 2563 developmental projects in cancer. In addition, there are 11 suspended drugs and the accumulated number of ceased drugs over the ...  |  read more...
USD 6,750
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... leads to activation of several non-receptor tyrosine kinases including those of the Src, Tec and Syk family of kinases. Downstream messengers include DAG, IP3, MAPK/ERK and JNK signaling modules. There are today 278 companies plus ...  |  read more...
USD 6,750
Biologicals in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... developing 2333 biological drugs in 5702 developmental projects in cancer. In addition, there are 27 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1017 drugs. Biologicals In ...  |  read more...
USD 11,025
Bladder Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... treated early, the 5 year survival rate is 94%. There are today 122 companies plus partners developing 149 drugs targeting bladder cancer in development. In addition, there are 3 suspended drugs and the accumulated number ...  |  read more...
USD 4,485
1    3    5  6  7  8  9  10